[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

July 2019 - April 2016

Decade

Year

Issue

June 2016, Vol 1, No. 3, Pages 243-368

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):243. doi:10.1001/jamacardio.2015.0014
Original Investigation

Geographic Variation in Trends and Disparities in Acute Myocardial Infarction Hospitalization and Mortality by Income Levels, 1999-2013

Abstract Full Text
free access has audio
JAMA Cardiol. 2016;1(3):255-265. doi:10.1001/jamacardio.2016.0382

This study examines the rates of decline in hospitalization and mortality related to acute myocardial infarction by US county income levels from 1999 to 2013.

Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non–Insulin-Treated Diabetes Mellitus: Secondary Analysis of the TUXEDO Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):266-273. doi:10.1001/jamacardio.2016.0305

This secondary analysis of the TUXEDO clinical trial assesses the outcomes of patients with insulin-treated diabetes mellitus vs non–insulin-treated diabetes mellitus who underwent percutaneous coronary intervention and assesses the efficacy and safety of everolimus-eluting stents vs paclitaxel-eluting stents based on insulin use status.

Seasonal Influenza Infections and Cardiovascular Disease Mortality

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):274-281. doi:10.1001/jamacardio.2016.0433

This time-series analysis of vital statistics records and emergency department visits in New York City of cardiovascular-related deaths quantifies the temporal association between seasonal influenza infections and mortality due to cardiovascular causes.

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

Abstract Full Text
open access
JAMA Cardiol. 2016;1(3):282-291. doi:10.1001/jamacardio.2016.0529

This observational cohort study aims to determine whether symptoms, quality of life, treatment, and outcomes differ between women and men with atrial fibrillation.

Implementation of a Regional Telephone Cardiopulmonary Resuscitation Program and Outcomes After Out-of-Hospital Cardiac Arrest

Abstract Full Text
free access has multimedia has audio
JAMA Cardiol. 2016;1(3):294-302. doi:10.1001/jamacardio.2016.0251

This before-after, observational study of adult patients with out-of-hospital cardiac arrest not receiving bystander cardiopulmonary resuscitation (CPR) before the 9-1-1 call investigates the effect of telephone CPR bundle of care on process measures and outcomes.

Association of Circulating MicroRNA-124-3p Levels With Outcomes After Out-of-Hospital Cardiac Arrest: A Substudy of a Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):305-313. doi:10.1001/jamacardio.2016.0480

This substudy of a randomized clinical trial assesses the prognostic value of circulating microRNA levels as biomarkers in patients with out-of-hospital cardiac arrest.

Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):314-321. doi:10.1001/jamacardio.2016.0316

This cohort study from the Society of Thoracic Surgeons Adult Cardiac Surgery Database examines the association of 5-m gait speed with operative mortality and morbidity in older adults undergoing cardiac surgery.

Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):324-332. doi:10.1001/jamacardio.2016.0252

This study examines in-hospital outcomes after septal myectomy and alcohol septal ablation stratified by hospital volume within a large, national inpatient database.

Brief Report

Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):335-340. doi:10.1001/jamacardio.2016.0225

This study characterizes the clinical profile and outcomes of typical vs atypical types of takotsubo syndrome in a large patient cohort from the International Takotsubo Registry.

Research Letter

Predictive Score for 30-Day Readmission or Death in Heart Failure

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):362-364. doi:10.1001/jamacardio.2016.0220

This study combines specific clinical and nonclinical factors to reliably predict 30-day readmission or death in heart failure.

Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):364-366. doi:10.1001/jamacardio.2016.0227

This post hoc analysis of a randomized clinical trial examines the effect of a family history of coronary heart disease on decision making to use statin therapy.

Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):366-368. doi:10.1001/jamacardio.2016.0393

This study compares incidence of stroke among patients with warfarin-treated atrial fibrillation with the incidence among similar-risk patients without atrial fibrillation to distinguish if on-treatment stroke is attributable to treatment failure or baseline risk.

Viewpoint

The Prospects for Cardiovascular Proteomics: A Glass Approaching Half Full

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):245-246. doi:10.1001/jamacardio.2016.0279

This Viewpoint examines strategies currently used in proteomic biomarker research and highlights advances that are beginning to provide describe how proteomics may move beyond the early stages of development and be applied to large-scale, population-based studies.

The Case for a Revised Definition of Myocardial Infarction—Resolving the Ambiguity of Type 2 Myocardial Infarction

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):247-248. doi:10.1001/jamacardio.2016.0511

This Viewpoint discusses the ambiguity of the current definition of myocardial infarction and describes the benefits of a narrower definition.

The Case for a Revised Definition of Myocardial Infarction—The Ongoing Conundrum of Type 2 Myocardial Infarction vs Myocardial Injury

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):249-250. doi:10.1001/jamacardio.2016.0543

This Viewpoint discusses the problematic definition of type 2 myocardial infarction and offers a solution in the near future.

From the Heart

The Summer Wind

Abstract Full Text
JAMA Cardiol. 2016;1(3):254. doi:10.1001/jamacardio.2016.1088
Editorial

Looking Beyond the Hospital to Reduce Acute Myocardial Infarction: Progress and Potential

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):251-253. doi:10.1001/jamacardio.2016.0544
Invited Commentary

Sex, Symptoms, and Atrial Fibrillation

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):292-293. doi:10.1001/jamacardio.2016.0545

The Resuscitative Power of a Telephone Call

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):302-304. doi:10.1001/jamacardio.2016.0278

Using Gait Speed to Refine Risk Assessment in Older Patients Undergoing Cardiac Surgery

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):321-323. doi:10.1001/jamacardio.2016.0380

Hypertrophic Cardiomyopathy—One Case per Year?A Clarion Call to Do What Is Right

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):333-334. doi:10.1001/jamacardio.2016.0277
Review

Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):341-349. doi:10.1001/jamacardio.2016.0218

This overview of systematic reviews assesses the efficacy and safety of aspirin, statins, blood pressure (BP)–lowering drugs, and tobacco cessation drugs for prevention of primary atherosclerotic cardiovascular disease.

Association of Coronary Stenosis and Plaque Morphology With Fractional Flow Reserve and Outcomes

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):350-357. doi:10.1001/jamacardio.2016.0263

This narrative review examines the associations of coronary artery stenosis, plaque morphology, and fractional flow reserve and the prognostic value of fractional flow reserve.

JAMA Cardiology Clinical Challenge

Fractional Flow Reserve in Serial Coronary Artery Stenoses

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):359-360. doi:10.1001/jamacardio.2016.0219

A man in his 70s who had undergone prior coronary artery bypass graft surgery presents with unstable angina; disease in the obtuse marginal branch appears stable, but there is worsening of disease in the ramus branch, where 2 serial lesions are identified. What would you do next?

Editor's Note

Process Improvement and Adopting the 2015 American Heart Association Resuscitation Guidelines

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):304. doi:10.1001/jamacardio.2016.0997

Procedural Volumes, Outcomes, and Quality in Hypertrophic Cardiomyopathy

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):334. doi:10.1001/jamacardio.2016.0711
Correction

Errors in Table and Text

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):368. doi:10.1001/jamacardio.2016.1550
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2016;1(3):244. doi:10.1001/jamacardio.2015.0015
×